CommercialAdministrativeMedium impact
Medical Specialty Drug Policies D F Archived
HMSA·HI · Oncology, Rheumatology, Endocrinology +2 more·Pharmacy
We identified it
Jun 20, 2026
Summary
HMSA has archived their Medical Specialty Drug Policies for categories D-F, meaning these policies are no longer active. This affects specialty drug coverage and prior authorization requirements for drugs in these categories.
Action Required
Immediately: Billing team should access the HMSA provider resource center to review which specific specialty drug policies have been archived and identify replacement policies. Contact HMSA directly to clarify current prior authorization requirements for specialty drugs previously covered under D-F policies. Update billing system rules to reflect any new specialty drug coverage criteria.